MHRA approves lurbinectedin for adults with extensive-stage small cell lung cancer
Imported from official source
As with all licensed medicines, the MHRA will keep the safety and effectiveness of lurbinectedin under close review.
This version
- Version
- 1 of 1
- Recorded
- September 23, 2026 17:00
- Change
- Initial
- Content hash
92be4b7d7da1ccade727a076a427dc60- All versions
- Revision history